Cite
HARVARD Citation
Funakoshi, Y. et al. (n.d.). ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application. Neuro-oncology advances. pp. ii7-ii8. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Funakoshi, Y. et al. (n.d.). ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application. Neuro-oncology advances. pp. ii7-ii8. [Online].